Canopy Growth Stock Falls 13% as Revenue Falls 25% on Lower Sales

Canopy Growth (TSX:WEED)(NASDAQ:CGC) stock beat earnings estimates in Q4 but saw net revenue drop year over year by 25%.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Canopy Growth (TSX:WEED)(NASDAQ:CGC) shares fell by 13% on Friday market open, as the company reported shrinking revenue on a year-over-year basis.

  • Canopy Growth stock beat earnings estimates of a loss of $0.31, posting a loss of $0.28 per share.
  • Net revenue fell 25% in the fourth quarter from the same time in 2021.
  • On a full-year basis, Canopy Growth stock reported $520 million in net revenue, down 5% from FY2021.

What happened in Q4 and FY2022 for Canopy Growth stock?

Canopy Growth stock climbed ahead of earnings on Thursday, up 11% at the close of the market. Analysts estimated the cannabis stock would bring in about $129 million in net revenue, yet the stock posted net revenue of $111.8 million for the fourth quarter. This resulted in shares losing all that growth by the time the market opened on Friday.

For the year, the net loss amounted to $320 million, a $1.35 billion improvement from full-year 2021. This came from fair-value changes and lower operating costs that included restructuring. Still, adjusted EBITDA increased to a loss of $122 million due to lower sales in Q4 and a loss of $415 million in FY2022. That was an increase of $75 million from the year before again from lower sales.

What did Canopy Growth management say?

The main goal of Canopy Growth stock remains to become profitable. From that, the company believes its BioSteel brand and further United States expansion will help create that profitability now that so many costs have been cut. It now maintains the number one spot of cannabis edibles in North America.

“We’ve taken concrete steps to advance this ambition by strengthening our positioning in Canada, and further bolstering our U.S. THC ecosystem through the addition of two high performance brands in Wana Brands and Jetty Extracts. In the fiscal year ahead, we will remain focused on growing our market share in the key segments that will drive profitable growth and continuing to scale our premium brands across North America.”

David Klein, chief executive officer of Canopy Growth

What’s next for Canopy Growth stock?

Analysts remain unconvinced about the future of Canopy Growth stock. In fact, even before earnings some analysts stated they hoped to see more cost-cutting initiatives. However, that doesn’t seem to have come to fruition.

Instead, it looks like it’s back to spending on expanding their edibles brands throughout North America, especially in the United States. But as for the next quarter, it’s likely lower sales will continue. Meanwhile, even though it’s still operating at a high loss, the company is back to focusing on investments in FY2023.

It looks like investors weren’t thrilled by the news with shares dropping immediately at the time of market open. Shares were down 13% at the time of writing and down 41% year to date.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »